Earnings
PLXP
7.36
-1.11%
-0.08
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
14.00M
--
--
18.68K
--
--
0.00
--
--
--
263.27K
0.00
14.28M
2.08M
--
--
--
2.06M
--
--
73.67K
4.22M
18.50M
--
928.92K
0.00
--
--
--
928.92K
--
1.51M
--
--
--
304.60K
6.09M
622.27K
--
--
--
10.22M
10.84M
16.93M
9160.00
74.84M
-86.94M
--
--
--
1.57M
1.57M
18.50M
FY 2018-12-31
14.25M
--
--
18.23K
--
--
0.00
--
0.00
--
409.37K
187.54K
14.87M
1.39M
--
--
--
2.06M
--
--
67.71K
3.52M
18.39M
--
653.05K
0.00
--
--
--
653.05K
--
1.17M
--
--
--
61.14K
4.73M
4.28M
--
--
--
2.93M
7.21M
11.94M
8740.00
72.87M
-66.44M
--
--
--
6.44M
6.44M
18.39M
FY 2017-12-31
24.40M
--
--
19.38K
--
--
0.00
--
246.37K
--
300.17K
719.67K
25.69M
1.03M
--
--
--
2.06M
--
--
67.71K
3.16M
28.85M
--
852.16K
0.00
--
--
--
852.16K
--
963.54K
--
--
--
59.61K
1.82M
6.94M
--
--
--
15.47M
22.42M
24.23M
8720.00
71.94M
-67.33M
--
--
--
4.62M
4.62M
28.85M
FY 2016-12-31
59.34K
--
--
5080.00
--
--
0.00
--
116.73K
--
4650.00
4060.00
189.85K
426.63K
--
--
--
0.00
0.00
--
0.00
426.64K
616.49K
--
863.00K
1.78M
--
--
--
863.00K
--
95.13K
--
--
--
--
2.74M
0.00
--
--
--
200.00K
200.00K
2.94M
4380.00
49.66M
-51.99M
--
--
--
-2.32M
-2.32M
616.49K
FY 2015-12-31
5.23M
26.98M
--
--
--
--
0.00
--
--
--
146.15K
--
32.36M
--
--
--
--
--
--
--
49.39K
49.39K
32.41M
--
--
0.00
--
--
--
28.06K
--
1.58M
--
--
--
--
1.61M
0.00
--
--
--
--
0.00
1.61M
10.30K
71.85M
-41.06M
--
--
--
30.80M
30.80M
32.41M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out PLXP latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze PLx Pharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.